Hemangiopericytoma (HPC) is a rare tumor originating from the mesenchyme.The morphology of the tumor, including positivity of the immunohistochemical marker CD34, showed predominant characteristics of the HPC. The patient has been subject to a follow-up for the past 84 months and no signs of recurrence or metastases were observed during this period.